Adverum Biotechnologies Announces Virtual Presentations of Data through ASGCT and ARVO
Abstracts are available online and presentations and posters can be accessed through ASGCT’s website on
Abstract Title (Oral): ADVM-022 Intravitreal Gene Therapy for Neovascular AMD - Results from the Phase 1 OPTIC Study
Session: AAV Vectors - Clinical Studies II
Date/Time:
Speaker: Szilárd Kiss, M.D., Director of Clinical Research in the
Abstract Title (Poster): Proof-of-Concept Studies in Mongolian Gerbils Support Intravitreal Gene Replacement Therapy of Human L-Opsin for Blue Cone Monochromacy
Session: AAV Vectors - Preclinical and Proof-of-Concept Studies
Date/Time:
Abstract Title (Poster): Large Scale Suspension Production of
Session: Vector and Cell Engineering, Production or Manufacturing
Date/Time:
The ARVO 2020 Annual Meeting has been cancelled and video-recorded presentations will be available online on ARVOLearn beginning
Abstract Title: Intravitreal Delivery of AAV2.7m8. Ranibizumab Suppresses Exudative Lesions in the NHP Laser Induced Model of nAMD
Abstract Title: Mouse Studies Support Intravitreal Gene Therapy for Blue Cone Monochromacy
About
Investor and Media Inquiries:
Investors:
mlacy@adverum.com
1-650-649-1257
Media:
ccecchini@lifescicomms.com
1-646-876-5196
Source: Adverum Biotechnologies, Inc.